Zobrazeno 1 - 10
of 76
pro vyhledávání: '"A. V Strygin"'
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova, O. V. Ivanova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 5, Pp 384-398 (2024)
The aim of the work was to conduct an analysis of the current state and current trends in the approval of drugs, as well as some aspects of the methodology for their development based on biological molecules and registration.Materials and methods. Th
Externí odkaz:
https://doaj.org/article/2dc8114950e748bbbd40243f3b14fe6b
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 347-380 (2024)
Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight t
Externí odkaz:
https://doaj.org/article/95f6d86f77b4438484e0b9ff432b4ee0
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 280-290 (2024)
Therapeutic drug monitoring (TDM) is used to increase the individualization of pharmacotherapy, especially in patient groups with a high interindividual variability in pharmacokinetic (PK) parameters. One of these groups of patients is newborn childr
Externí odkaz:
https://doaj.org/article/ca68963d8b8f45b89606e67601361cde
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 193-210 (2023)
The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were u
Externí odkaz:
https://doaj.org/article/8583ca5a7d4043de9ab1b0dd5ccb0858
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev, A. V. Baskova, S. S. Polodyants, A. V. Kasparova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 2, Pp 104-113 (2023)
The aim of the study was to evaluate a cerebroprotective activity of the sitagliptin and aminoguanidine combination in rats with an acute and chronic cerebral circulation insufficiency, as well as with a traumatic brain injury.Materials and methods.
Externí odkaz:
https://doaj.org/article/91ea2398488e41cb8546951fb823d06b
Autor:
Vladimir I. Petrov, Ivan S. Anikeev, Tatyana E. Zayachnikova, Andrey V. Strygin, Anna M. Dotsenko
Publikováno v:
Research Results in Pharmacology, Vol 9, Iss 2, Pp 55-59 (2023)
Introduction: Reduced mortality in patients with sepsis taking piperacillin is possible when they receive a long-term infusion, which improves the effect of antimicrobials. However, such piperacillin therapy requires therapeutic drug monitoring, the
Externí odkaz:
https://doaj.org/article/41fe9f3ba77a4f1797955836227a5e10
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 1, Pp 19-47 (2023)
Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in th
Externí odkaz:
https://doaj.org/article/f0fe50a3b67f4dd0bc0505b700df9935
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 6, Pp 536-548 (2023)
The aim of the work was to determine the antidiabetic effect of a sitagliptin and aminoguanidine combination in rats with experimental diabetes mellitus.Materials and methods. The study was carried out on male Wistar rats and C57BL/KsJ-db/db mice. Ac
Externí odkaz:
https://doaj.org/article/01e777c11d2e46abbb84447ee403e55c
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 4, Pp 331-342 (2022)
To control the concentration of drugs with a narrow therapeutic range, and to conduct effective and safe treatments, Therapeutic Drug Monitoring (TDM) is carried out. However, to date, the implementation of TDM is associated with various difficulties
Externí odkaz:
https://doaj.org/article/e849d9b69a16416e889b02158dfc1551
Autor:
D. V. Kurkin, E. E. Abrosimova, D. A. Bakulin, N. S. Kovalev, M. A. Dubrovina, A. V. Borisov, A. V. Strygin, E. I. Morkovin, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 2, Pp 130-153 (2022)
Nitric oxide as a therapeutic approach to the treatment of cardiovascular diseases attracted the attention of researchers at the end of the 19th century. As a vasodilator, nitric oxide may be a unique therapeutic agent for the treatment of hypertensi
Externí odkaz:
https://doaj.org/article/4e3fff5c12294271b8cf6f647278d606